Browsing by Author "Eroglu, E."
Now showing 1 - 1 of 1
- Results Per Page
- Sort Options
Item Impact of proactive low-molecular weight heparin therapy on outcomes in COVID-19(AEPRESS SRO, 2021-01-01) Gormez, S.; Gumusel, H. K.; Ekicibasi, E.; Degirmencioglu, A.; Paudel, A.; Akan, G.; Atalar, F.; Erdim, R.; Eroglu, E.; Dagdelen, S.; Sariguzel, N.; Kirisoglu, C. E.; Pamukcu, B.OBJECTIVES: Low molecular weight heparin (LMWH) may provide beneficial effects on outcomes of COVID-19. We aimed to examine the impact of LMWH treatment on clinical outcomes (duration of hospitalization, admission to intensive care unit, the requirement for mechanical ventilation, and death) of COVID-19 patients with normal D-dimer levels at admission. BACKGROUND: Coronavirus disease-2019 (COVID-19) predisposes patients to arterial and venous thrombosis. METHODS: In this retrospective, multicentre and observational study we analysed the data of 308 confirmed COVID-19 patients with normal D-dimer levels at initial admission. After propensity score matching (PSM) patients were grouped